Drugs / Endosequence Bio ceramic Sealer
Endosequence Bio ceramic Sealer
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 0 | NCT05816772 | Oct 2022 → Apr 2023 | — | Dow University of Health Sciences | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Endosequence Bio ceramic Sealer | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05816772 ↗ |
| Modality | Other / unclassified | “a nano-particulate injectable premixed bioceramic sealer” NCT05816772 ↗ |
| Route | Other | “Sealer was introduced into the canal” NCT05816772 ↗ |